ChEMBL ID: CHEMBL3545373
Mechanism of action: CD276 antigen cross-linking agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to ENOBLITUZUMAB